CITIGROUP ($C) posted quarterly earnings results on Tuesday, October 14th. The company reported earnings of $2.24 per share, beating estimates of $1.94 by $0.30. The company also reported revenue of $22,090,000,000, beating estimates of $21,508,629,115 by $581,370,885.
You can see Quiver Quantitative's $C stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CITIGROUP Insider Trading Activity
CITIGROUP insiders have traded $C stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $C stock by insiders over the last 6 months:
- JOHN CUNNINGHAM DUGAN sold 4,417 shares for an estimated $301,492
- PETER B. HENRY sold 3,000 shares for an estimated $271,209
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CITIGROUP Hedge Fund Activity
We have seen 1,013 institutional investors add shares of CITIGROUP stock to their portfolio, and 889 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 8,503,284 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $723,799,534
- CITADEL ADVISORS LLC added 5,367,317 shares (+2689.3%) to their portfolio in Q2 2025, for an estimated $456,866,023
- NUVEEN, LLC added 5,312,921 shares (+65.1%) to their portfolio in Q2 2025, for an estimated $452,235,835
- FMR LLC removed 5,143,350 shares (-17.7%) from their portfolio in Q2 2025, for an estimated $437,801,952
- GOLDMAN SACHS GROUP INC removed 5,088,777 shares (-35.0%) from their portfolio in Q2 2025, for an estimated $433,156,698
- BARCLAYS PLC removed 2,685,308 shares (-36.3%) from their portfolio in Q2 2025, for an estimated $228,573,416
- CAPITAL WORLD INVESTORS removed 2,537,715 shares (-5.4%) from their portfolio in Q2 2025, for an estimated $216,010,300
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CITIGROUP Congressional Stock Trading
Members of Congress have traded $C stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $C stock by members of Congress over the last 6 months:
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 06/18.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CITIGROUP Analyst Ratings
Wall Street analysts have issued reports on $C in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 09/24/2025
- Oppenheimer issued a "Outperform" rating on 09/23/2025
- Wells Fargo issued a "Overweight" rating on 09/16/2025
- Barclays issued a "Overweight" rating on 07/16/2025
- Piper Sandler issued a "Overweight" rating on 07/16/2025
- Morgan Stanley issued a "Overweight" rating on 07/03/2025
- Goldman Sachs issued a "Buy" rating on 07/02/2025
To track analyst ratings and price targets for CITIGROUP, check out Quiver Quantitative's $C forecast page.
CITIGROUP Price Targets
Multiple analysts have issued price targets for $C recently. We have seen 11 analysts offer price targets for $C in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- Betsy Graseck from Morgan Stanley set a target price of $129.0 on 09/29/2025
- John McDonald from Truist Securities set a target price of $112.0 on 09/24/2025
- Chris Kotowski from Oppenheimer set a target price of $123.0 on 09/23/2025
- Mike Mayo from Wells Fargo set a target price of $125.0 on 09/16/2025
- Steven Alexopoulos from TD Cowen set a target price of $95.0 on 07/16/2025
- Jason Goldberg from Barclays set a target price of $100.0 on 07/16/2025
- Scott Siefers from Piper Sandler set a target price of $104.0 on 07/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
